biomedicina slovenica


"GROWTH FACTORS" : 184

  1. Semenič Danijela
    Odziv različnih tipov kroničnih ran na topikalno aplicirane rastne faktorje
    [Response to different types of chronic wounds to topical application of growth factors]
    2019
  2. Vlačić Gregor; Hoda Mir Alireza; Klikovits Thomas; Sinn Katharina; Gschwandtner Elisabeth; Mohorčič Katja; Schelch Karin; Pirker Christine; Peter-Vörösmarty Barbara; Brankovic Jelena; Čufer Tanja; Rozman Aleš; Kern Izidor
    Expression of FGFR1-4 in malignant pleural mesothelioma tissue and corresponding cell lines and its relationship to patient survival and FGFR inhibitor sensitivity
    2019
  3. Zupan Janja; Vrtačnik Peter; Cör Andrej; Haring Gregor; Weryha Georges; Visvikis-Siest Sophie; Marc Janja
    VEGF-A is associated with early degenerative changes in cartilage and subchondral bone
    2019
  4. Škorjanec Sandra; Dolovski Zdravko; Kocman Ivan; Brcic Luka; Boban Blagaic Alenka; Batelja Lovorka; Coric Marjana; Sever Marko; Klicek Robert; Kolenc Danijela
    Therapy for unhealed gastrocutaneous fistulas in ratsas a model for analogous healing of persistent skin woundsand persistent gastric ulcers
    2009
  5. Sikirić Predrag; Seiwerth Sven; Ručman Rudolf; Kolenc Danijela; Batelja Vuletic Lovorka; Drmić Domagoj; Grgic Tihomir; Strbe Sanja; Zukanovic Goran; Crvenkovic Dalibor
    Brain-gut axis and pentadecapeptide BPC 157
    2016
  6. Cirman Tina; Železnik Ramuta Taja; Lužnik Zala; Hawlina Marko; Schollmayer Petra; Smrke Dragica; Erdani-Kreft Mateja
    Amnijska membrana kot biološki nosilec, njena priprava in uporaba v regenerativni medicini v Sloveniji
    [The amniotic membrane as a biological scaffold, its preparation and use in regenerative medicine in Slovenia]
    2018
  7. Kouter Katarina; Videtič Paska Alja
    Epigenetika in samomorilno vedenje
    [Epigenetics and suicidal behaviour]
    2018
  8. Grogan James A.; Connor Anthony J.; Markelc Boštjan; Muschel Ruth J.; Maini Philip K.; Byrne Helen; Pitt-Francis Joe
    Microvessel chaste
    2017
  9. Trošt Nuša; Stojan Jure; Fon Tacer Klementina; Križaj Igor
    Vloga proteina [gama]-Klotho v signalni poti fibroblastnega rastnega dejavnika 19 in njegov vpliv na preživetje ter proliferacijo rakavih celic
    [The role of [gamma]-Klotho protein in the signaling pathway of fibroblast growth factor 19 and its effect on survival and proliferation of cancer cells]
    2016
  10. Kotnik Mojca; Duratović Konjević Amela; Lokar Katarina; Bernot Marjana; Jezeršek Novaković Barbara; Pečnik Tjaša
    Izzivi sodobnih pristopov onkološke zdravstvene nege in zdravljenja
    2009
  11. Ocvirk Janja
    Klinična uporaba zdravila bevacizumab v onkologiji
    2009
  12. Ovčariček Tanja; Ravnik Maja; Gregorič Brigita
    Antiangiogena terapija
    2009
  13. Čegovnik Urška; Menart Viktor; Galvani Vesna; Novaković Srdjan
    Expression of hTNF-[alpha] gene in transfected mammalian B16 melanoma cells
    1999
  14. Stem cells, growth factors and cancer
    1999
  15. Pišlar Anja; Perišić Milica; Kos Janko
    Lysosomal cysteine peptidases - molecules signaling tumor cell death and survival
    2015
  16. Hojski Aljaž; Leitgeb Maja; Crnjac Anton
    Release of growth factors after mechanical and chemical pleurodesis for treatment of malignant pleural effusion
    2015
  17. Rošic Romana; Kristl Julijana; Baumgartner Saša
    Hidrogelne obloge za vlažno celjenje ran s proteinsko učinkovino
    [Protein loaded hydrogels as dressing for moist wound healing]
    2010
  18. Ocvirk Janja
    Anti-angiogenic therapy for malignant gliomas
    2009
  19. Pečovnik-Balon Breda; Ekart Robert; Gorenjak Maksimiljan
    FGF 23 in clinical practice?
    2012
  20. Globočnik Petrovič Mojca
    From molecular to clinical cignificance of growth factors and cytokines in proliferative diabetic retinopathy
    2012
  21. Podergajs Neža; Brekka Narve; Radlwimmer Bernhard; Herold-Mende Christel; Talasila Krishna M.; Tiemann Katja; Rajčević Uroš; Lah Turnšek Tamara; Bjerkvig Rolf; Miletic Hrvoje
    Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF
    2013
  22. Bulgin Dmitry; Vrabič Erik; Hodzic Enes
    Autologous bone-marrow-derived-mononuclear-cells-enriched fat transplantation in breast augmentation
    2013
  23. Campos Marcos Iván; Marolt Darja; Petridis Petros; Bhumiratana Sarindr; Schmidt Daniel; Vunjak-Novakovic Gordana
    Bone scaffold architecture modulates the development of mineralized bone matrix by human embryonic stem cells
    2012
  24. Trošt Rupnik Alijana; Pajek Jernej; Guček Andrej; Osredkar Joško; Kovač Damjan; Bren Andrej; Klančič Dimitrij; Saksida Silvana; Rus Igor; Globokar Mateja; Drozg Andrej; Lešnik Marjeta; Plešivčnik Zala; Ekart Robert; Kralj Lopert Simona; Lindič Jelka
    Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients
    2013
  25. Černelč Peter; Sever Matjaž
    Naše izkušnje zdravljenja z azacitidinom pri bolnikih z akutno mieloično levkemijo, kronično mielomonocitno levkemijo in mielodisplastičnim sindromom
    [Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome]
    2012
  26. Sever Matjaž; Podgornik Helena; Mlakar Uroš; Černelč Peter
    Lastnosti bolnikov z mielodisplastičnim sindromom in njihova obravnava na kliničnem oddelku za hematologijo, UKC Ljubljana, v obdobju 2008-2012
    [Myelodysplastic syndrome patient characteristics and treatment at University medical center Ljubljana between 2008-2012]
    2012
  27. Rozman Aleš; Šilar Mira; Košnik Mitja
    Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients
    2012
  28. Balantič M; Rijavec M; Škerbinjek-Kavalar M; Šuškovič S; Šilar M; Košnik M; Korošec P
    Asthma treatment outcome in children Is associated with vascular endothelial growth factor A (VEGFA) polymorphisms
    2012
  29. Vogrin Matjaž
    The role of growth factors in ACL surgery
    2011
  30. Kristan SS; Marc MM; Kern I; Fležar M; Šuškovič S; Košnik M; Korošec P
    Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease
    2012
  31. Ocvirk Janja; Reberšek Martina; Boc Marko
    Bevacizumab in first-line therapy of metastatic colorectal cancer: a retrospective comparison of FOLFIRI and XELIRI
    2011
  32. Jurič Damijana M; Mele Tina; Čarman-Kržan Marija
    Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes
    2011
  33. Globočnik-Petrovič Mojca; Korošec Petra; Košnik Mitja; Hawlina Marko
    Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy
    2010
  34. Kraut Aleksandra; Sevšek Davorin; Jaki-Mekjavić Polona; Urbančič Mojca
    Kombinirano zdravljenje neovaskularne oblike starostne degeneracije makule s fotodinamičnim zdravljenjem in ranibizumabom - 2 letno poročilo
    [Combination therapy for neovascular form of agerelated macular degeneration with photodynamic therapy and ranizumab - 2 year report]
    2010
  35. Pirkmajer Sergej; Filipovič Dragana; Marš Tomaž; Miš Katarina; Grubič Zoran
    HIF-1alpha response to hypoxia is functionally separated from the glucocorticoid stress response in the in vitro regenerating human skeletal muscle
    2010
  36. Gan Hui Kong; Šeruga Boštjan; Knox Jennifer J
    Targeted therapies for renal cell carcinoma: more gains from using them again
    2009
  37. Vogrin Matjaž; Rupreht Mitja; Crnjac Anton; Dinevski Dejan; Krajnc Zmago; Rečnik Gregor
    The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study
    2010
  38. Naranđa Jakob; Vogrin Matjaž
    Novi biološki pristopi pri rekonstrukciji sprednje križne vezi (ACL)
    [New biological approaches in the reconstruction of anterior cruciate ligament (ACL)]
    2010
  39. Petrovič D
    The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease
    2010
  40. Grubič Zoran
    Nevrobiologija depresije
    [Neurobiology of depression]
    2010
  41. Kovačič Uroš; Sketelj Janez; Bajrović Fajko F
    Age-related differences in the reinnervation after peripheral nerve injury
    2009
  42. Gašperšič R; Kovačič U; Glišovič Š; Coer A; Skalerič U
    Anti-NGF treatment reduces bone resorption in periodontitis
    2010
  43. Mele Tina; Čarman-Kržan Marija; Jurič Damijana Mojca
    Regulatory role of monoamine neurotransmitters in astrocytic NT-3 synthesis
    2009
  44. Velnar Tomaž; Bailey Tracey; Smrkolj Vladimir
    The wound healing process: an overview of the cellular and molecular mechanisms
    2009
  45. Kastelic Damjana
    Identification of markers and development of protein biochips for characterization of proteome and typing of maligannt tissues
    [Identifikacija označevalcev in razvoj proteinskih biočipov za določanje proteoma in tpizacijo malignih tkiv]
    2009
  46. Vogrin Matjaž
    Uporaba novih bioloških modelov pri rekonstrukciji sprednje križne vezi kolenskega sklepa
    [Use of new biological models in anterior cruciate ligament reconstruction surgery]
    2009
  47. Krainc Dimitri; Bai Guang; Okamoto Shu-ichi; Carles Maria; Kusiak John W; Brent Roger N; Lipton Stuart A
    Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1
    1998
  48. Jaki- Mekjavič Polona; Kraut Aleksandra; Urbančič Mojca; Lenassi Eva; Hawlina Marko
    Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections
    2009
  49. Fon-Tacer Klementina
    Citokromi P450, jedrni receptorji in fibroblastni rastni dejavniki - nove endokribne osi kot potencialna prijemališča za zdravljenje presnovnih bolezni
    [Cytochromes P450, nuclear receptors, and fibroblast growth factors - new endocrine axes as potential drug targets to treat metabolic disorders]
    2009
  50. Kristan SS; Malovrh MM; Šilar M; Kern I; Fležar M; Košnik M; Šuškovič S; Korošec P
    Airway angiogenesis in patients with rhinitis and controlled asthma
    2009
  51. Globočnik-Petrovič Mojca; Korošec Peter; Košnik Mitja; Osredkar Joško; Hawlina Marko; Peterlin Borut; Petrovič Danijel
    Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy
    2008
  52. O'Connor Jason C; McCusker Robert H; Strle Klemen; Johnson Rodney W; Dantzer Robert; Kelley Keith W
    Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology
    2008
  53. Shen Wen Hong; Jackson Steve T; Broussard Suzzane R; McCusker Robert H; Strle Klemen; Freund Gregory G; Johnson Rodney W; Dantzer Robert; Kelley Keith W
    IL-1beta suppresses prolonged Akt activation and expression of E2F-1 and cyclin A in breast cancer cells
    2004
  54. Zhou Jian-Hua; Broussard Suzzane R; Strle Klemen; Freund Gregory G; Johnson Rodney W; Dantzer Robert; Kelley Keith W
    IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3'-kinase
    2001
  55. Aleš K; Wraber B; Lipnik-Štangelj M
    The synergistic effect of histamine and IL-6 on NGF secretion from cultured astrocytes is evoked by histamine stimulation of IL-6 secretion via H(1)-receptor-PKC-MAPK signalling pathway
    2008
  56. Smrke Dragica Maja; Gubina Borut; Domanovič Dragan; Bolta Zoran; Rožman Primož
    Uporaba trombocitnih rastnih dejavnikov v travmatologiji
    [(The use of platelet growth factors in the traumatology)]
    2007
  57. Rožman P; Bolta Z
    Use of platelet growth factors in treating wounds and soft-tissue injuries
    2007
  58. Blinc Aleš; Golli Tanja; Cerar-Vodnik Alenka; Zver Samo
    Concurrent thalidomine and radiation therapy for extensive arterio-venous malformations
    2008
  59. Košir Roman; Čretnik Andrej
    Tkivno inženirstvo pri zdravljenju zlomov
    [Tissue engineering in fracture treatment]
    2007
  60. Southgate RJ; Neill B; Prelovšek O; El-Osta A; Kamei Y; Miura S; Ezaki O; McLoughlin TJ; Zhang W; Unterman TG
    FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle
    2007
  61. Smrke Dragica; Gubina Borut; Domanović Dragoslav; Rožman Primož
    Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect
    2007
  62. Perdan Katja; Pirkmajer Sergej
    Vpliv nevrotrofina NT-3 na funkcionalne sposobnosti motonevronov v kokulturi s človeško mišico?
    [The effect of neurotrophin NT-3 on functional capabilities of motoneurons in cocultures with human muscle]
    2006
  63. Globočnik-Petrovič Mojca
    Vpliv genetskih in biokemičnih dejavnikov na napredovanje in zdravljenje diabetične retinopatije pri diabetesu tipa 2
    [The influence of genetical and biochemical factors for the progression and treatment of diabetic retinopathy in type 2 diabetes]
    2007
  64. Domanović Dragoslav
    Pomen želatinaze B (metaloproteinaze - 9) za zbiranje krvotvornih matičnih celic
    2006
  65. Arroyo Jorge G
    76-letni bolnik s starostno degeneracijo rumene pege
    [A 76-year-old man with macular degeneration]
    2006
  66. Špička Nenad; Kraut Aleksandra
    Starostna degeneracija rumene pege
    2006
  67. Rečnik Gregor
    Biologija celjenja zlomov kosti v naravi in v kirurgiji
    [Biological basis of fracture healing in vivo in surgery]
    2006
  68. Petrovič Danijel; Verhovec Renata; Globočnik-Petrovič Mojca; Osredkar Joško; Peterlin Borut
    Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes
    2007
  69. Lipnik-Štangelj M; Čarman-Kržan M
    Effects of histamine and IL-1beta on PKC-stimulated nerve growth factor secretion from glial cells
    2006
  70. Blinc Aleš
    Angiogeneza - terapevtska tarča pri zdravljenju raka in arterijske okluzivne bolezni
    2006
  71. Trpin-Katarić Anita
    Nevrobiologija depresivnih motenj
    2006
  72. Ehrenreich M; Ruszczak Z
    Tissue-engineered temporary wound coverings. Important options for the clinician
    2006
  73. Glaser Marjana
    Growth characteristics of circulating hematopoietic progenitors in terminal renal failure
    2006
  74. Marš T; Jevšek M
    Nerve growth factors promote functional innervation of cultured human skeletal muscle
    2005
  75. Zakotnik Branko; Matos Erika
    Gastrointestinalni stromalni tumorji
    [Gastrointestinal stromal tumors]
    2005
  76. Planinšek-Ručigaj Tanja; Lunder Tomaž
    Venska golenja razjeda: zdraviti s pripravkom koncentriranih trombocitov ali ne?
    2004
  77. Tomažič A; Pegan V; Ferlan-Marolt K; Pleskovič A; Luzar B
    Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma
    2004
  78. Velenik Vaneja
    Solidni tumorji ter nova spoznanja pri zdravljenju bolnikov z rakom
    [Solid tumors and new developments in cancer patients treatment]
    2005
  79. Bajrović Fajko F
    Vnetni posredniki in periferni nevron
    2005
  80. Gradišnik Suzana; Pahor Artur; Holc Iztok
    Osteoporoza in revmatske bolezni
    [Osteoporosis and rheumatic diseases]
    2005
  81. Šebeštjen Miran
    Novi dejavniki tveganja za aterosklerozo: pomen in možnosti zdravljenja
    2005
  82. Štempelj Mateja; Ferjan Ilonka
    Živčni rastni dejavnik - njegova vloga pri astmi in alergijskih reakcijah
    [Nerve growth factor - its role in asthma and allergic reactions]
    2005
  83. Vrtačnik-Bokal E; Meden-Vrtovec H; Virant-Klun I; Verdenik I
    Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome
    2005
  84. Lipnik-Štangelj M; Čarman-Kržan M
    Histamine and IL-6 interaction in the stimulation of nerve growth factor secretion from cultured astrocytes
    2005
  85. Verhovec Renata
    Polimorfizem gena za žilni endotelijski rastni dejavnik - genetski označevalec koronarne bolezni pri bolnikih s sladkorno boleznijo tipa 2
    2005
  86. Čebašek Vita
    Prilagoditev kapilarne mreže skeletnih mišic podgane po poškodbi živca
    2004
  87. Perdan Katja; Pirkmajer Sergej
    Vpliv nevrotrofina NT-3 na funkcionalne sposobnosti motonevronov v kokulturi s človeško mišico
    2004
  88. Drevenšek Gorazd
    Novi pristopi k zdravljenju raka
    2005
  89. Štempelj Mateja
    Mehanizem sproščanja histamina iz mastocitov podgane po aktivaciji z živčnim rastnim dejavnikom
    2004
  90. Szepietowski JC; Reich A; McKenzie RC
    The multifunctional role of leukaemia inhibitory factor in cutaneous biology
    2004
  91. Bajrović Fajko
    Dolgoročni učinki neugodnih razmer ob poškodbi perifernega živca na uspeh regeneracije
    1992
  92. Caserman S; Lah TT
    Comparison of expression of cathepsins B and L and MMP2 in andothelial cells and in capillary sprouting in collagen gel
    2004
  93. Štrukelj Borut
    Sprememba strukture proteoglikanov v procesu staranja kože
    2004
  94. Miklič Špela
    Modulacija sinteze nevrotrofičnega dejavnika možganskega izvora (BDNF) v primarni kulturi astrocitov novorojenih podgan
    [Brain-derived neurotrophic factor (BDNF) synthesis modulation in neonatal rat astrocytes in primary culture]
    2004
  95. Lipnik-Štangelj M; Čarman-Kržan M
    Histamine-stimulated nerve growth factor secretion from cultured astrocytes is blocked by protein kinase C inhibitors
    2004
  96. Lipnik-Štangelj M; Čarman-Kržan M
    Activation of histamine H1-receptor enhances neurotrophic factor secretion from cultured astrocytes
    2004
  97. Miklič Špela; Jurič Damijana Mojca; Čarman-Kržan Marija
    Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes
    2004
  98. Caserman Simon
    Vloga proteoliznih encimov pri invazivni rasti endotelijskih celic med procesom angiogeneze
    2004
  99. Tomažič Aleš; Pleskovič Alojz; Ferlan-Marolt Vera; Luzar Boštjan; Pegan Vladislav
    Napovedni dejavniki preživetja bolnikov po resekciji periampularnega adenokarcinoma
    [Survival predictors after resection of periampullar adenocarcinoma]
    2004
  100. Tomažič Aleš
    Napodedni dejavniki preživetja bolnikov po resekciji periampularnega karcinoma
    2003

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics